Published in J Invest Dermatol on August 01, 1988
Lithium regulates keratinocyte proliferation via glycogen synthase kinase 3 and NFAT2 (nuclear factor of activated T cells 2). J Cell Physiol (2012) 0.92
Keratinocyte secretion of cyclophilin B via the constitutive pathway is regulated through its cyclosporin-binding site. J Invest Dermatol (2011) 0.82
Cyclosporin A, FK506 and dithranol after tyrosine-specific protein phosphorylation in HaCaT keratinocytes. Arch Dermatol Res (1995) 0.75
Effect of cyclosporins A, G, and H on normal and ichthyotic keratinocyte growth in culture. Arch Dermatol Res (1992) 0.75
Pathophysiology of premature skin aging induced by ultraviolet light. N Engl J Med (1997) 4.57
Propagation of a human herpesvirus from AIDS-associated Kaposi's sarcoma. N Engl J Med (1997) 3.90
Molecular basis of sun-induced premature skin ageing and retinoid antagonism. Nature (1996) 3.83
Keratinocytes as initiators of inflammation. Lancet (1991) 3.68
Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N Engl J Med (1982) 3.09
Restoration of collagen formation in photodamaged human skin by tretinoin (retinoic acid) N Engl J Med (1993) 3.06
Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci U S A (1993) 2.86
Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: modulation by recombinant gamma interferon and tumor necrosis factor. J Am Acad Dermatol (1989) 2.77
Increased concentrations of nonesterified arachidonic acid, 12L-hydroxy-5,8,10,14-eicosatetraenoic acid, prostaglandin E2, and prostaglandin F2alpha in epidermis of psoriasis. Proc Natl Acad Sci U S A (1975) 2.75
Dermal injection of immunocytes induces psoriasis. J Clin Invest (1996) 2.64
Overexpression of transforming growth factor alpha in psoriatic epidermis. Science (1989) 2.63
Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functionally distinctive subsets. J Immunol (1993) 2.55
CD-34 is expressed by a distinctive cell population in peripheral nerve, nerve sheath tumors, and related lesions. Am J Surg Pathol (1993) 2.54
Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan. Hum Mol Genet (1997) 2.48
Home blood pressure determination. Value in borderline ("labile") hypertension. JAMA (1974) 2.16
Topical tretinoin (retinoic acid) therapy for hyperpigmented lesions caused by inflammation of the skin in black patients. N Engl J Med (1993) 2.15
NOTCH signaling as a novel cancer therapeutic target. Curr Cancer Drug Targets (2006) 2.14
A photonumeric scale for the assessment of cutaneous photodamage. Arch Dermatol (1992) 2.11
Linkage analysis of human leukocyte antigen (HLA) markers in familial psoriasis: strong disequilibrium effects provide evidence for a major determinant in the HLA-B/-C region. Am J Hum Genet (1998) 2.09
Comparison of CD271 (adapalene) and all-trans retinoic acid in human skin: dissociation of epidermal effects and CRABP-II mRNA expression. J Invest Dermatol (1993) 2.07
Pruritus associated with nocturnal wakenings: organic or psychogenic? J Am Acad Dermatol (1989) 2.06
The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. J Invest Dermatol (1993) 2.04
Kaposiform hemangioendothelioma of infancy and childhood. An aggressive neoplasm associated with Kasabach-Merritt syndrome and lymphangiomatosis. Am J Surg Pathol (1993) 2.04
Vitamin A antagonizes decreased cell growth and elevated collagen-degrading matrix metalloproteinases and stimulates collagen accumulation in naturally aged human skin. J Invest Dermatol (2000) 1.97
Quantification of cutaneous sensory nerves and their substance P content in psoriasis. J Invest Dermatol (1989) 1.96
Cyclosporine improves psoriasis in a double-blind study. JAMA (1986) 1.95
Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C. Am J Hum Genet (2000) 1.86
The cytokine network in psoriasis. Arch Dermatol (1991) 1.85
The genetics of psoriasis. Arch Dermatol (1994) 1.84
Psoralen plus black light inhibits epidermal DNA synthesis. Arch Dermatol (1973) 1.75
Mycosis fungoides exhibits a Th1-type cell-mediated cytokine profile whereas Sezary syndrome expresses a Th2-type profile. J Invest Dermatol (1994) 1.73
Characterization of dermal dendritic cells in psoriasis. Autostimulation of T lymphocytes and induction of Th1 type cytokines. J Clin Invest (1994) 1.71
Keratinocytes: key immunocytes of the integument. Am J Pathol (1993) 1.69
Molecular mechanisms of retinoid actions in skin. FASEB J (1996) 1.69
Effect of topical cyclosporine rinse on oral lichen planus. A double-blind analysis. N Engl J Med (1990) 1.68
Sulfasalazine therapy for psoriatic arthritis: a double blind, placebo controlled trial. J Rheumatol (1995) 1.68
Topical tretinoin improves photoaged skin. A double-blind vehicle-controlled study. JAMA (1988) 1.65
Cationic lipid is not required for uptake and selective inhibitory activity of ICAM-1 phosphorothioate antisense oligonucleotides in keratinocytes. J Invest Dermatol (1994) 1.63
Characterization of factor XIIIa positive dermal dendritic cells in normal and inflamed skin. Br J Dermatol (1989) 1.60
Alcohol intake and treatment responsiveness of psoriasis: a prospective study. J Am Acad Dermatol (1993) 1.60
Recombinant gamma interferon induces HLA-DR expression on cultured human keratinocytes. J Invest Dermatol (1984) 1.60
Reduced type I and type III procollagens in photodamaged adult human skin. J Invest Dermatol (1995) 1.60
Ultraviolet irradiation of human skin causes functional vitamin A deficiency, preventable by all-trans retinoic acid pre-treatment. Nat Med (1999) 1.56
Retinoic acid inhibits induction of c-Jun protein by ultraviolet radiation that occurs subsequent to activation of mitogen-activated protein kinase pathways in human skin in vivo. J Clin Invest (1998) 1.55
Marked synergism between tumor necrosis factor-alpha and interferon-gamma in regulation of keratinocyte-derived adhesion molecules and chemotactic factors. J Clin Invest (1990) 1.54
Activation of dendritic antigen-presenting cells expressing common heat shock protein receptor CD91 during induction of psoriasis. Br J Dermatol (2005) 1.53
Sulfasalazine improves psoriasis. A double-blind analysis. Arch Dermatol (1990) 1.53
Claudin-1 overexpression in melanoma is regulated by PKC and contributes to melanoma cell motility. Oncogene (2006) 1.53
Oral cyclosporine for severe chronic idiopathic urticaria and angioedema. J Am Acad Dermatol (1991) 1.52
Immunohistochemical detection of papillomavirus antigens in Kaposi's sarcoma. Lancet (1992) 1.52
A morphometric and histologic study of the scalp in psoriasis. Paradoxical sebaceous gland atrophy and decreased hair shaft diameters without alopecia. Arch Dermatol (1989) 1.51
Ciclosporin in psoriasis clinical practice: an international consensus statement. Br J Dermatol (2004) 1.51
Cyclosporine in dermatology. J Am Acad Dermatol (1989) 1.50
c-Jun-dependent inhibition of cutaneous procollagen transcription following ultraviolet irradiation is reversed by all-trans retinoic acid. J Clin Invest (2000) 1.50
Keratinocyte intercellular adhesion molecule-1 (ICAM-1) expression precedes dermal T lymphocytic infiltration in allergic contact dermatitis (Rhus dermatitis). Am J Pathol (1989) 1.47
Molecular mechanisms of nonablative fractionated laser resurfacing. Br J Dermatol (2010) 1.47
Proceedings of the Psoriasis Combination and Rotation Therapy Conference. Deer Valley, Utah, Oct. 7-9, 1994. J Am Acad Dermatol (1996) 1.45
Behçet's disease. Int J Dermatol (1984) 1.45
Bulimia nervosa and acne may be related: a case report. Can J Psychiatry (1992) 1.44
Molecular mechanisms of photoaging and its prevention by retinoic acid: ultraviolet irradiation induces MAP kinase signal transduction cascades that induce Ap-1-regulated matrix metalloproteinases that degrade human skin in vivo. J Investig Dermatol Symp Proc (1998) 1.43
Inhibition of type I procollagen synthesis by damaged collagen in photoaged skin and by collagenase-degraded collagen in vitro. Am J Pathol (2001) 1.42
IL-10 production in cutaneous basal and squamous cell carcinomas. A mechanism for evading the local T cell immune response. J Immunol (1995) 1.42
Anal cancer incidence: genital warts, anal fissure or fistula, hemorrhoids, and smoking. J Natl Cancer Inst (1989) 1.42
Inocoterone and acne. The effect of a topical antiandrogen: results of a multicenter clinical trial. Arch Dermatol (1992) 1.41
Cyclosporine in the treatment of psoriatic arthritis. Arch Dermatol (1989) 1.41
Stratification, specialization, and proliferation of primary keratinocyte cultures. Evidence of a functioning in vitro epidermal cell system. J Cell Biol (1978) 1.40
Duration of remission during maintenance cyclosporine therapy for psoriasis. Relationship to maintenance dose and degree of improvement during initial therapy. Arch Dermatol (1995) 1.40
Notch-1 associates with IKKalpha and regulates IKK activity in cervical cancer cells. Oncogene (2008) 1.40
Topical retinoic acid (tretinoin) for melasma in black patients. A vehicle-controlled clinical trial. Arch Dermatol (1994) 1.39
Sulfasalazine: a potential psoriasis therapy? J Am Acad Dermatol (1989) 1.39
IL-1 activity is reduced in psoriatic skin. Decreased IL-1 alpha and increased nonfunctional IL-1 beta. J Immunol (1990) 1.39
Lymphocytic infiltrates of the skin in association with cyclosporine therapy. J Am Acad Dermatol (1990) 1.39
Antiproliferative effects of recombinant alpha- and gamma-interferons on cultured human keratinocytes. Lab Invest (1984) 1.38
Overexpression of CD1d by keratinocytes in psoriasis and CD1d-dependent IFN-gamma production by NK-T cells. J Immunol (2000) 1.37